Company research / CORZ

Core Scientific, Inc./tx (CORZ)

Also trades as CORZR, CORZW, CORZZ. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

CIK 0001839341 · Nasdaq · Finance Services

  • Sector Finance & Real Estate
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Core Scientific, Inc./tx reported revenue of $319.02M. Revenue fell 37.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $440.31M.

Key ratios (year ended 2025-12-31)

11.9%
Gross margin
-77.0%
Operating margin
-90.5%
Net margin
-37.5%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-20

Headquarters locality: Dover · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312024-09-302024-06-302023-12-312022-12-312021-12-312020-12-31
Revenue$440.31M$319.02M$510.67Mn/an/a$502.40M$640.31M$544.48M$60.32M
Cost of Revenue$315.50M$281.12M$389.60Mn/an/a$378.94M$631.91M$305.62M$50.93M
Gross Profit$124.81M$37.90M$121.07Mn/an/a$123.46M$8.40M$238.86M$9.39M
R&D Expensen/an/a$11.83Mn/an/a$7.18M$26.96M$7.67M$5.27M
Operating Income-$561.16M-$245.59M-$142.06Mn/an/a$8.96M-$2.11B$131.49M-$6.33M
Depreciation & Amortization$62.57M$68.91M$113.20Mn/an/a$96.00M$225.26M$33.36M$9.40M
EBITDA-$498.58M-$176.68M-$28.86Mn/an/a$104.96M-$1.88B$164.86M$3.08M
Net Income-$1.43B-$288.62M-$1.44Bn/an/a-$246.49M-$2.15B$47.31M-$12.21M
EPS (Diluted)n/a-$0.88-$4.87n/an/a-$0.65-$6.30$0.20-$0.14
Total Assets$5.26B$2.35B$1.48B$824.59M$664.20M$712.16M$807.69M$2.44Bn/a
Total Liabilities$7.68B$3.31B$2.42Bn/an/a$1.31B$1.22B$1.05Bn/a
Shareholders' Equity-$2.42B-$962.74M-$943.05M-$826.66M-$1.18B-$596.94M-$409.35M$1.34B$89.22M
Cash & Equivalents$1.77B$311.38M$836.20Mn/an/a$50.41M$15.88M$117.87Mn/a
Operating Cash Flow$520.24M$278.25M$42.90Mn/an/a$65.11M$205.19M-$56.73M-$23.77M
Capital Expenditures$1.48B$729.00M$94.96Mn/an/a$16.16M$383.98M$0$0
Free Cash Flow-$957.75M-$450.75M-$52.06Mn/an/a$48.95M-$178.79M-$56.73M-$23.77M
Share Repurchasesn/an/a$0n/an/a$0$31.65Mn/an/a
Shares Outstanding319.59M314.23M292.61Mn/an/a386.88M375.23M271.58Mn/a
Weighted Average Diluted Sharesn/a318.07M255.83Mn/an/a379.86M340.65M233.31M157.60M
EPS (Basic)n/a-$0.88-$4.87n/an/a-$0.65-$6.30$0.23-$0.14

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView